← Open Payments lookup

DENISE BLACKBOURNE: Open Payments

NPI 1356623961 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$315 in 13 payments from 11 companies in 2025. Trend: 2023 $158 · 2024 $140 · 2025 $315

Food & beverage: $315
CompanyPaymentsAmount
Stemline Therapeutics Inc.2$60
Novartis Pharmaceuticals Corporation2$50
Boston Scientific Corporation1$31
Genentech USA, Inc.1$28
Daiichi Sankyo Inc.1$25
Bayer Healthcare Pharmaceuticals Inc.1$25
Incyte Corporation1$22
ABBVIE INC.1$21
Merck Sharp & Dohme LLC1$18
MILLICENT US INC1$18

Products named: Orserdu, KISQALI, Upsylon, Itovebi, Enhertu, Lynkuet, ZYNYZ, VENCLEXTA.

Industry payments across MD — which companies pay providers there.